Including Lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer

Affiliations

¹ Unit of Medical Oncology 1, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Ospedale Policlinico San Martino, Genoa. Electronic address: stefania.sciallero@hsanmartino.it.
² Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa; Department of Informatics, Bioengineering, Robotics and Systems Engineering, University of Genoa, Genoa.
³ Unit of Hereditary Cancer, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Ospedale Policlinico San Martino, Genoa, Italy.

Free article

Comment

S Sciallero et al. Ann Oncol. 2017.

Free article

. 2017 Oct 1;28(10):2620-2621.

doi: 10.1093/annonc/mdx292.

¹ Unit of Medical Oncology 1, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Ospedale Policlinico San Martino, Genoa. Electronic address: stefania.sciallero@hsanmartino.it.
² Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa; Department of Informatics, Bioengineering, Robotics and Systems Engineering, University of Genoa, Genoa.
³ Unit of Hereditary Cancer, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Ospedale Policlinico San Martino, Genoa, Italy.

No abstract available

Comment in

Reply to the letter to the editor 'Including lynch syndrome in personalized prognostication and follow-up of stage II and III colon cancer' by Sciallero et al.
Dienstmann R, Guinney J. Dienstmann R, et al. Ann Oncol. 2017 Nov 1;28(11):2889-2890. doi: 10.1093/annonc/mdx415. Ann Oncol. 2017. PMID: 29045507 No abstract available.

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.
Dienstmann R, Mason MJ, Sinicrope FA, Phipps AI, Tejpar S, Nesbakken A, Danielsen SA, Sveen A, Buchanan DD, Clendenning M, Rosty C, Bot B, Alberts SR, Milburn Jessup J, Lothe RA, Delorenzi M, Newcomb PA, Sargent D, Guinney J. Dienstmann R, et al. Ann Oncol. 2017 May 1;28(5):1023-1031. doi: 10.1093/annonc/mdx052. Ann Oncol. 2017. PMID: 28453697 Free PMC article.